about
Bone morphogenetic protein 4ETS transcription factor ERGGATA binding protein 4Erb-b2 receptor tyrosine kinase 3Bone morphogenetic protein receptor type 2NEDD4 E3 ubiquitin protein ligaseCysteine rich with EGF like domains 1Forkhead box F1T-box transcription factor 5RNA binding motif protein 24Transmembrane protein 100Bone morphogenetic protein receptor, type II (serine/threonine kinase)ETS transcription factorGATA binding protein 4Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2Ephrin type-A receptor 3T-box 5Forkhead box F1Neural precursor cell expressed, developmentally down-regulated 4Erb-b2 receptor tyrosine kinase 3Notch 1RNA binding motif protein 24Transmembrane protein 100Thrombospondin-1GATA binding protein 4Transmembrane protein 100Notch receptor 1Forkhead box F1Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2Bone morphogenetic protein receptor type 2Bone morphogenetic protein 4Notch receptor 1Forkhead box F1Bone morphogenetic protein 4Bone morphogenetic protein 4
P682
Q14903410-2B65F5DC-7672-4BB5-8638-E131F5E48482Q21097223-F60E0C7B-1C7E-4BF7-93E0-E0D8D3DB32BCQ21101542-767900A5-3600-445C-A2B1-70E82169A49AQ21104746-A3DB4ECC-0D70-477B-B038-29140855F5BCQ21106712-A2283993-181C-4357-A629-418A0FA3DB89Q21107331-DE9C198A-595B-43B5-9A69-EF259076E937Q21108438-860AE762-66FE-4434-B2ED-372B03230E3AQ21108593-86C133D0-2F72-444A-AA2E-27F940D1CFAAQ21114550-878B4731-CA73-4AF6-82F6-BB7C46A7AA8AQ21125047-93C492CE-8A4C-46EF-8031-072425188A68Q21132170-914588D0-F60C-4971-82B9-4B0E262B2F24Q21495412-CFD01C06-3E14-4B2A-B246-FF41BE3521C4Q21495564-B1C80C2E-AB08-48E9-92AD-9EAA83831A16Q21497814-A0AA93B9-FF23-4A18-8053-F69BCBB731FCQ21499275-CBF859B3-1FF2-4ED5-AEDF-67786E789DD9Q21979767-A67DA794-1803-4A96-9FB1-A62354A1855AQ21980213-AECFE933-B5E1-42FD-9A41-E0A3D5F0BCA5Q21983985-A1DA71A5-388F-4676-87B1-A210C76E3551Q21984113-4342EC32-1E26-4B93-B2DC-A7208B2F248DQ21984810-7FCB78CC-D2B3-4047-B7D8-9E7FA5AA05B3Q21986193-39612B2F-29FC-4766-A08D-EDADC18649A0Q21990504-11B5493E-49F6-48FD-AB64-3349434FE097Q21992193-1A467449-1092-4F5E-8828-14B87F683EDAQ21992233-FF65FCDA-6C7E-4375-ABC9-83555BE715A2Q28557718-079BE0AB-F9F3-487F-B049-7C1BAB363FA2Q28559301-2F52684F-F8A1-4848-B30C-A16653902FD4Q28561098-6F0DF4FA-4E16-40C4-A3F0-E1BBDE95EE50Q29516844-36A1F3F3-EB6F-48EB-AF03-7FA39BE223A3Q29519419-48F7409B-8467-4B22-A831-FACD6D934D65Q29520781-53EDA18B-8228-410C-848E-DD902261AF59Q29523318-94042837-D29B-4E36-B34F-45F77D6F4CC7Q4044985-2E478898-3FAA-40C1-9599-A222611FEEF9Q55198774-65AABA11-A18E-4430-9BEC-4D31BD442319Q55203583-C4FCD3A8-A7F5-4FF0-84CE-B64A2410EE66Q700001-2D686F7C-4038-493B-B4C7-C27B94531C03
P682
description
The progression of a cardiac c ...... to the heart septa and valves.
@en
biologisch proces
@nl
name
endocardial cushion development
@en
utvikling av endokardpute
@nn
type
label
endocardial cushion development
@en
utvikling av endokardpute
@nn
altLabel
GO:0003197
@en
prefLabel
endocardial cushion development
@en
utvikling av endokardpute
@nn
P2888
P686
GO:0003197